Herrera et al., 1989 - Google Patents
Unilateral induction of c-fos protein in cortex following cortical devascularizationHerrera et al., 1989
- Document ID
- 1939597265027043707
- Author
- Herrera D
- Robertson H
- Publication year
- Publication venue
- Brain research
External Links
Snippet
The proto-oncogene c-fos is rapidly induced by a variety of stimuli including wounding of the cortex. In an attempt to define the conditions necessary for c-fos activation, we have studied the effects of cerebral devascularization (CD; unilateral pial disruption), a procedure which …
- 230000001054 cortical 0 title description 20
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Herrera et al. | Unilateral induction of c-fos protein in cortex following cortical devascularization | |
| Roberts et al. | Suppression of NMDA receptor function using antisense DNA blocks ocular dominance plasticity while preserving visual responses | |
| Gage et al. | NGF receptor reexpression and NGF-mediated cholinergic neuronal hypertrophy in the damaged adult neostriatum | |
| Karpiak et al. | Gangliosides (GM1 and AGF2) reduce mortality due to ischemia: protection of membrane function. | |
| Pellegrino et al. | Schwann cell mitosis in response to regenerating peripheral axons in vivo | |
| DE69028694T2 (en) | METHOD AND PREPARATIONS FOR TREATING CANCER WITH OLIGONUCLEOTIDES | |
| Kornblum et al. | Induction of brain derived neurotrophic factor mRNA by seizures in neonatal and juvenile rat brain | |
| Lin et al. | Hypothalamo‐preoptic histaminergic projections in sleep‐wake control in the cat | |
| Anderson et al. | Effect of thyroxine and cortisol on brain ornithine decarboxylase activity and swimming behavior in developing rat | |
| JP5736397B2 (en) | Formulations containing antisense nucleotides against connexins | |
| Morin et al. | Hypothalamic progesterone implants and facilitation of lordosis behavior in estrogen-primed ovariectomized guinea pigs | |
| Mezei et al. | Liposomes-a selective drug delivery system for the topical route of administration I. Lotion dosage form | |
| Herrera et al. | Application of potassium chloride to the brain surface induces the c-fos proto-oncogene: reversal by MK-801 | |
| Clarke et al. | Prolonged administration of NT-4/5 fails to rescue most axotomized retinal ganglion cells in adult rats | |
| DeGeorge et al. | Arecoline‐stimulated brain incorporation of intravenously administered fatty acids in unanesthetized rats | |
| Lockshin et al. | Programmed cell death: new thoughts and relevance to aging | |
| Zhao et al. | Environmental influence on brain-derived neurotrophic factor messenger RNA expression after middle cerebral artery occlusion in spontaneously hypertensive rats | |
| US8828959B2 (en) | Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells | |
| Matthews et al. | Spinal cord transection: a quantitative analysis of elements of the connective tissue matrix formed within the site of lesion following administration of piromen, cytoxan or trypsin | |
| VERMOUTH et al. | Prolactin release induced by prostaglandin F2α in pregnant rats | |
| Pollack et al. | D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons | |
| Karpiak et al. | Gangliosides accelerate rat neonatal learning and levels of cortical acetylcholinesterases | |
| Williams et al. | Molecular events in the spinal cord following sensory stimulation | |
| YUGUCHI et al. | Expression of growth inhibitory factor mRNA following cortical injury in rat | |
| DE69429539T2 (en) | INHIBITING THE EXTRACELLULAR MATRIX SYNTHESIS BY ANTISENSE COMPOSITIONS AGAINST C-MYC |